BioRestorative Therapies (BRTX) Accumulated Depreciation & Amortization (2017 - 2024)
Historic Accumulated Depreciation & Amortization for BioRestorative Therapies (BRTX) over the last 12 years, with Q4 2024 value amounting to $1.1 million.
- BioRestorative Therapies' Accumulated Depreciation & Amortization rose 981.47% to $1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year increase of 981.47%. This contributed to the annual value of $1.1 million for FY2024, which is 981.47% up from last year.
- As of Q4 2024, BioRestorative Therapies' Accumulated Depreciation & Amortization stood at $1.1 million, which was up 981.47% from $1.0 million recorded in Q4 2023.
- BioRestorative Therapies' 5-year Accumulated Depreciation & Amortization high stood at $1.1 million for Q4 2024, and its period low was $878994.0 during Q4 2020.
- Its 5-year average for Accumulated Depreciation & Amortization is $966284.8, with a median of $935839.0 in 2022.
- In the last 5 years, BioRestorative Therapies' Accumulated Depreciation & Amortization soared by 166.47% in 2021 and then soared by 981.47% in 2024.
- Over the past 5 years, BioRestorative Therapies' Accumulated Depreciation & Amortization (Quarter) stood at $878994.0 in 2020, then grew by 1.66% to $893627.0 in 2021, then increased by 4.72% to $935839.0 in 2022, then rose by 8.12% to $1.0 million in 2023, then rose by 9.81% to $1.1 million in 2024.
- Its last three reported values are $1.1 million in Q4 2024, $1.0 million for Q4 2023, and $935839.0 during Q4 2022.